NCT06844357 2025-04-06A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.Zhejiang Raygene Pharmaceuticals Co., LtdPhase 2/3 Recruiting300 enrolled